CSI Market
Sign In | Register

Ventyx Biosciences Inc (VTYX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access VTYX Annual Cash Flow →
The quarterly cash flow data below helps track how Ventyx Biosciences Inc's liquidity profile has evolved over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2025)
9 Months 		(Jun 30 2025) (Mar 31 2025) (Dec 31 2024) (Sep 30 2024)
Operating Activities
Income-77.26
Depreciation & amortization0.22
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Long-Lived Assets Held-for-use0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
Research and Development in Process0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation14.21
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Interest Expense Related Party-
Change In Fair Value Of Notes And Derivative Related Party-
Operating Lease Right Of Use Asset Amortization Expense0.79
Gain Loss On Termination Of Lease-
Accretion Of Marketable Securities-3.97
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable-2.14
Increase (Decrease) in Accrued Liabilities0.49
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets3.93
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.77
Discontinued operations0.00
Net Cash flow from Operating Activities-64.50
Investing Activities
Capital Expenditures-0.11
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Available-for-sale Securities156.89
Payments to Acquire Available-for-sale Securities, Debt-88.12
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities68.66
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.27
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-28.24
Amendment To Convertible Promissory Notes Related Party-
Debt Conversion Converted Instrument Amount-
Stock Issued-
Deferred Offering Costs Unpaid-
Unrealized Gain Loss On Securities Non Cash-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations28.24
Proceeds From Issuance Of Common Stock From At The Market Offering Net Of Commissions And Offering Expenses-
Proceeds From Issuance Of Non Voting Convertible Peferred Stock From Private Placement Net Of Offering Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.27
Effect of exchange rate on cash flow0.28
Discontinued operations0.00
Free Cash Flow-64.61
Total Cash Flow4.71
4 historic quarters locked

Sign in to unlock the full Ventyx Biosciences Inc cash flow history.

Sign In Create Free Account

About Ventyx Biosciences Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-25-269517

Figures are derived from filed reports and may be restated. Historical data is subject to revision.